Anterior Segment Expertise

Lexitas has supported more than 125 anterior segment studies, partnering with sponsors from early feasibility through late-phase development. Our team combines specialized clinical expertise, led by CMO and cornea specialist David Tanzer, MD and Nevin-El-Nimri, OD, PhD, with disciplined endpoint management, integrated imaging and reading center capabilities, and proactive site support to generate reliable, regulatory-aligned data and support efficient study execution.
Key Indications

• Cataract and Refractive: Presbyopia, Myopia, Contact Lens, IOLs, post-operative pain, Cataract therapies
• Corneal Disease: Neurotrophic Keratitis, PCED, Neuropathic Corneal Pain, and endothelial disorders
• Ocular Surface Disease: Dry Eye, Blepharitis/MGD, and Bacterial Conjunctivitis
• Glaucoma

Retina Expertise

Lexitas has supported more than 45 posterior segment studies, providing the specialized clinical, imaging, and operational expertise needed to advance complex development programs. Our team delivers imaging-driven study strategies, standardized endpoint management, disciplined execution, and long-term operational planning to help sponsors generate high-quality, regulatory-aligned data. Through our partnership with Erie Retina Research and the appointment of David Almeida, MD, as Chief Retina Strategy Officer, sponsors also gain access to a premier ophthalmic research center and recognized clinical leadership.
Key Indications

• Neovascular and Intermediate AMD & Geographic Atrophy
• Diabetic Retinopathy & Diabetic Macular Edema
• Inherited Retinal Diseases including LCA, Retinitis Pigmentosa, and Stargardt disease
• Anatomic Abnormalities including retinal detachment retinoschisis
• Cell & Gene Therapy Programs

Device Expertise

Through our strategic partnership with NAMSA, Lexitas provides ophthalmic device sponsors with access to an integrated development team that combines specialized ophthalmology expertise with global medical device development capabilities. Together, we serve as a single, accountable partner across the product lifecycle, from early development through clinical execution and commercialization.

Lexitas experts work within NAMSA’s project structure, SOPs, and quality system, creating a truly unified delivery model rather than a traditional subcontractor relationship. From IDE strategy through PMCF, you have one accountable partner and a streamlined path from development to submission. To learn more visit the NAMSA website.